Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.Dik J. Kwekkeboom, Eric P. Krenning, Thomas M. O’Dorisio et al.|PubMed|2005Cited by 375
Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogueBice Chini, Gianni Bussolati, Marco Chinol et al.|British Journal of Cancer|2003Cited by 36
111In-labeled 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid-lys(8)-vasotocin: a new powerful radioligand for oxytocin receptor-expressing tumors.Gianni Bussolati, Giovanni Paganelli, Paola Cassoni et al.|PubMed|2001Cited by 13